View |
|
DRP-13675-01
|
Levofloxacin (as hemihydrate)
|
Unbranded
|
500 mg/100 mL
|
Solution for IV Infusion
|
Antibacterial (Fluoroquinolone)
|
Bosch Pharmaceuticals (Pvt) Ltd
|
Pakistan
|
Renewal
|
28 August 2024
|
29 September 2029
|
View |
|
DRP-13681-02
|
Ursodeoxycholic Acid
|
Ursostar 300
|
300 mg
|
Film-Coated Tablet
|
Bile and Liver Therapy (Bile acids and derivative)
|
Sapphire Lifesciences Pvt. Ltd
|
India
|
CLIDP Conversion
|
28 September 2023
|
24 March 2028
|
View |
|
DRP-13686-01
|
Losartan Potassium
|
None
|
100 mg
|
Film-Coated Tablet
|
Angiotensin II Receptor Blocker (ARB)
|
Magbro Healthcare Pvt. Ltd.
|
India
|
CLIDP Conversion
|
11 October 2023
|
28 March 2028
|
View |
|
DRP-13687-01
|
Losartan Potassium
|
None
|
50 mg
|
Film-Coated Tablet
|
Angiotensin II Receptor Blocker (ARB)
|
Magbro Healthcare Pvt. Ltd.
|
India
|
CLIDP Conversion
|
04 October 2023
|
28 March 2028
|
View |
|
DRP-13801-02
|
Sugammadex (as Sodium)
|
SugamaGet 200
|
100 mg / mL
|
Solution for Injection (IV)
|
Antidote
|
Aspiro Pharma Limited
|
India
|
CLIDP Conversion
|
12 October 2023
|
27 April 2028
|
View |
|
DRP-13802-01
|
Sugammadex (as Sodium)
|
SugamaGet 500
|
100 mg / mL
|
Solution for Injection (IV)
|
Antidote
|
Aspiro Pharma Limited
|
India
|
CLIDP Conversion
|
11 October 2023
|
27 April 2028
|
View |
|
DRP-13817-01
|
Cefotaxime (as sodium)
|
None
|
1 g
|
Powder for Injection (I.M./I.V.)
|
Antibacterial (Cephalosporins)
|
Bosch Pharmaceutical (Pvt.) Ltd.
|
Pakistan
|
CLIDP Conversion
|
03 October 2023
|
15 October 2028
|
View |
|
DRP-13828-01
|
Mupirocin
|
Bactestop
|
20mg/g (2%w/w)
|
Topical Ointment
|
Antibacterial
|
East African (India) Overseas
|
India
|
CLIDP Conversion
|
13 September 2023
|
27 April 2028
|
View |
|
DRP-14003-01
|
Febuxostat
|
Xozid
|
40 mg
|
Film-Coated Tablet
|
Anti-gout (Preparation Inhibiting Uric Acid Production)
|
Globela Pharma Private Limited
|
India
|
CLIDP Conversion
|
11 September 2023
|
02 June 2028
|
View |
|
DRP-14065-01
|
Ceftriaxone (as sodium)
|
Tricexone
|
1 g
|
Powder for Injection (IM/IV)
|
Antibacterial (Cephalosporin)
|
Swiss Parenterals Inc.
|
India
|
CLIDP Conversion
|
10 October 2023
|
13 June 2028
|
View |
|
DRP-14065-02
|
Ceftriaxone (as sodium)
|
Nikkoxone
|
1 g
|
Powder for Injection (IM/IV)
|
Antibacterial (Cephalosporin)
|
Swiss Parenterals Ltd
|
India
|
CLIDP Conversion
|
06 October 2023
|
13 June 2028
|
View |
|
DRP-14065-03
|
Ceftriaxone (as sodium)
|
Cefont
|
1 g
|
Powder for Injection (IM/IV)
|
Antibacterial (Cephalosporin)
|
Swiss Parenterals Ltd.
|
India
|
CLIDP Conversion
|
03 October 2023
|
13 June 2028
|
View |
|
DRP-14065-04
|
Ceftriaxone (as sodium)
|
Protriaxone
|
|
1 g Powder for Injection (IM/IV)
|
Antibacterial (Cephalosporin)
|
Swiss Parenterals Ltd.
|
India
|
CLIDP Conversion
|
03 October 2023
|
13 June 2028
|
View |
|
DRP-14091-01
|
Metformin Hydrochloride
|
Fored
|
500 mg
|
Film-Coated Tablet
|
Blood Glucose - Lowering Drug (Biguanide)
|
Mercury Laboratories Ltd.
|
India
|
CLIDP Conversion
|
11 September 2023
|
20 June 2028
|
View |
|
DRP-14130-01
|
Rosuvastatin (as Calcium)
|
None
|
20 mg
|
film coated tablet
|
HMG CoA reductase inhibitor
|
Rhydburg Pharmaceuticals Ltd
|
India
|
CLIDP Conversion
|
11 September 2023
|
10 February 2026
|
View |
|
DRP-1421-05
|
Omeprazole
|
Omepsol
|
20 mg
|
Capsule
|
Proton Pump Inhibitor
|
Centurion Laboratories Pvt. Ltd
|
India
|
CLIDP Conversion
|
03 October 2023
|
10 July 2028
|
View |
|
DRP-14225-01
|
Metoclopramide Hydrochloride
|
Metocirc
|
5 mg / mL
|
Solution for Injection (IM/IV)
|
Gastrokinetic (Prokinetic)
|
Scott-Edil Pharmacia Ltd.
|
India
|
CLIDP Conversion
|
14 September 2023
|
27 December 2027
|
View |
|
DRP-1425-16
|
Amoxicillin (as Trihydrate)
|
TGMOX
|
250 mg/5 mL
|
Powder for Suspension
|
Antibacterial (Penicillin)
|
J.M. Tolmann Laboratories Inc.
|
Philippines
|
CLIDP Conversion
|
11 September 2023
|
21 November 2026
|
View |
|
DRP-1426-13
|
Cefalexin (as Monohydrate)
|
Xelares
|
250 mg/5 mL
|
Powder for Suspension (Strawberry Flavor)
|
Antibacterial (Cephalosporin)
|
J.M. Tolmann Laboratories Inc.
|
Philippines
|
CLIDP Conversion
|
13 September 2023
|
05 February 2027
|
View |
|
DRP-1431-09
|
Amoxicillin (as trihydrate)
|
Amoxstan
|
500 mg
|
Capsule
|
Antibacterial (Penicillin)
|
J.M. Tolmann Laboratories Inc.
|
Philippines
|
CLIDP Conversion
|
11 September 2023
|
02 August 2027
|